Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53. (Q39383957)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53. (English)

1 reference

Europe PubMed Central

11 September 2017

apoptotic process

0 references

protein ubiquitination

1 reference

based on heuristic

inferred from title

author name string

Nian-Kang Sun

1

1 reference

Europe PubMed Central

11 September 2017

Shang-Lang Huang

2

1 reference

Europe PubMed Central

11 September 2017

Kun-Yi Chien

3

1 reference

Europe PubMed Central

11 September 2017

Chuck C-K Chao

4

1 reference

Europe PubMed Central

11 September 2017

language of work or name

0 references

publication date

1 June 2012

1 reference

Europe PubMed Central

11 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Biochemical Journal

1 reference

Europe PubMed Central

11 September 2017

444

1 reference

Europe PubMed Central

11 September 2017

303-314

1 reference

Europe PubMed Central

11 September 2017

2

1 reference

Europe PubMed Central

11 September 2017

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Drug resistance reversal--are we getting closer?

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Cisplatin: mode of cytotoxic action and molecular basis of resistance

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Cisplatin resistance and oncogenes--a review

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Cellular processing of platinum anticancer drugs

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Mechanisms of resistance to cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Knockdown of NAPA using short-hairpin RNA sensitizes cancer cells to cisplatin: implications to overcome chemoresistance

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Clinical implications of p53 mutations

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

p21 in cancer: intricate networks and multiple activities

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Blinded by the Light: The Growing Complexity of p53

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Oscillations and bistability in the stochastic model of p53 regulation.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

The p53 family and programmed cell death

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

The relevance of protein-protein interactions for p53 function: the CPE contribution.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Small-molecule inhibitors of the p53-MDM2 interaction

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

GS28, a 28-kilodalton Golgi SNARE that participates in ER-Golgi transport

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

A v-SNARE implicated in intra-Golgi transport

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Protein interactions regulating vesicle transport between the endoplasmic reticulum and Golgi apparatus in mammalian cells

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Membrane vesicles as conveyors of immune responses

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Restoration of UV sensitivity in UV-resistant HeLa cells by antisense-mediated depletion of damaged DNA-binding protein 2 (DDB2).

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Mdm2: p53's lifesaver?

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

N-Ethylmaleimide-sensitive factor (NSF) and alpha-soluble NSF attachment proteins (SNAP) mediate dissociation of GS28-syntaxin 5 Golgi SNAP receptors (SNARE) complex

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

p53 isoforms can regulate p53 transcriptional activity.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

p53 isoforms gain functions

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

The isoforms of the p53 protein

1 reference

https://api.crossref.org/works/10.1042%2FBJ20112223

21 January 2018

Identifiers

10.1042/BJ20112223

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39383957&oldid=2034870214"